Menu Search
Equities

Novozymes A/S

NZM2:BRN

Novozymes A/S

Actions
  • Price (CHF)48.28
  • Today's Change0.00 / 0.00%
  • Shares traded300.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Feb 02 2023.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Novozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. The Company operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. It develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Adisseo, Beta Renewables, DONG Energy and Monsanto, and is a parent company of Novozymes Belgium BVBA, Novozymes BioAg Limited, Novozymes Canada Limited, Albumedix A/S and Organobalance GmbH, among others.

  • Revenue in DKK (TTM)17.55bn
  • Net income in DKK3.68bn
  • Incorporated2000
  • Employees6.44k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		NZYM B:CPH since
announced		Transaction
value
Chr Hansen Holding A/SAnnounced12 Dec 202212 Dec 2022Announced-18.65%1.81bn
Chr Hansen Holding A/SAnnounced12 Dec 202212 Dec 2022Announced-18.65%9.62bn
Data delayed at least 15 minutes, as of Mar 27 2023 15:59 BST.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.